
Sign up to save your podcasts
Or


Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Forbes Media LLC4.8
66 ratings
Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

91,267 Listeners

500 Listeners

16 Listeners

5 Listeners